{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T06:57:23Z","timestamp":1760079443990,"version":"build-2065373602"},"reference-count":25,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resuscitationjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Resuscitation"],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1016\/j.resuscitation.2009.09.027","type":"journal-article","created":{"date-parts":[[2009,11,14]],"date-time":"2009-11-14T05:03:52Z","timestamp":1258175032000},"page":"47-52","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Nifekalant versus lidocaine for in-hospital shock-resistant ventricular fibrillation or tachycardia"],"prefix":"10.1016","volume":"81","author":[{"given":"Tsuyoshi","family":"Shiga","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiji","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rinya","family":"Kato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mari","family":"Amino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuji","family":"Matsudo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshihiro","family":"Honda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichi","family":"Sagara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takao","family":"Katoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuyoshi","family":"Urashima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teruo","family":"Takano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Kasanuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.resuscitation.2009.09.027_bib1","first-page":"IV-58","article-title":"2005 American Heart Association Guidelines for cardiopulmonary resuscitation and emergency cardiovascular care. Part 7.2. Management of cardiac arrest","volume":"112","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.resuscitation.2009.09.027_bib2","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1056\/NEJM199909163411203","article-title":"Amiodarone for resuscitation after out-of-hospital cardiac arrest due to ventricular fibrillation","volume":"341","author":"Kudenchuk","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.resuscitation.2009.09.027_bib3","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1056\/NEJMoa013029","article-title":"Amiodarone as compared with lidocaine for shock-resistant ventricular fibrillation","volume":"346","author":"Dorian","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.resuscitation.2009.09.027_bib4","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1476-5381.1993.tb13546.x","article-title":"Effects of MS-551, a new class III antiarrhythmic drug, on action potential and membrane currents in rabbit ventricular myocytes","volume":"109","author":"Nakaya","year":"1993","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.resuscitation.2009.09.027_bib5","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0021-5198(19)39753-7","article-title":"Antiarrhythmic effects of MS-551, a new class III antiarrhythmic agent, on canine models of ventricular arrhythmia","volume":"58","author":"Kamiya","year":"1992","journal-title":"Jpn J Pharmacol"},{"key":"10.1016\/j.resuscitation.2009.09.027_bib6","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1111\/j.1540-8159.1995.tb03863.x","article-title":"Electrophysiological effects of MS-551 in humans: a class III antiarrhythmic agent","volume":"18","author":"Isomoto","year":"1995","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.resuscitation.2009.09.027_bib7","first-page":"1759","article-title":"Efficacy of intravenous doses of MS-551 for drug-resistant sustained ventricular tachycardia","volume":"13","author":"Onishi","year":"1997","journal-title":"J Clin Ther Med"},{"key":"10.1016\/j.resuscitation.2009.09.027_bib8","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1054\/jelc.2001.24380","article-title":"Electrophysiological characteristic of a patient exhibiting the short-coupled variant of torsade de pointes","volume":"34","author":"Shiga","year":"2001","journal-title":"J Electrocardiol"},{"key":"10.1016\/j.resuscitation.2009.09.027_bib9","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1253\/circj.69.1237","article-title":"Emergency treatment with nifekalant, a novel class III anti-arrhythmic agent, for life-threatening refractory ventricular tachyarrhythmias. Post-marketing special investigation","volume":"69","author":"Katoh","year":"2005","journal-title":"Circ J"},{"key":"10.1016\/j.resuscitation.2009.09.027_bib10","first-page":"127","article-title":"Efficacy of nifekalant hydrochloride for life-threatening ventricular tachyarrhythmias in patients with resistance to lidocaine: a study of patients with out-of-hospital cardiac arrest","volume":"41","author":"Amino","year":"2003","journal-title":"J Cardiol"},{"key":"10.1016\/j.resuscitation.2009.09.027_bib11","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3918\/jsicm.11.105","article-title":"The effectiveness of nifekalant for out-of-hospital cardiopulmonary arrest with intractable ventricular fibrillation","volume":"11","author":"Shimizu","year":"2004","journal-title":"J Jpn Soc Intensive Care Med"},{"key":"10.1016\/j.resuscitation.2009.09.027_bib12","doi-asserted-by":"crossref","first-page":"S155","DOI":"10.1111\/j.1540-8159.2005.00043.x","article-title":"Defibrillation effects of nifekalant in patients with out-of-hospital ventricular fibrillation","volume":"28","author":"Igarashi","year":"2005","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.resuscitation.2009.09.027_bib13","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1253\/circj.70.21","article-title":"Can nifekalant hydrochloride be used as a first-line drug for cardiopulmonary arrest (CPA)? Comparative study of out-of-hospital CPA with acidosis and in-hospital CPA without acidosis","volume":"70","author":"Yoshioka","year":"2006","journal-title":"Circ J"},{"key":"10.1016\/j.resuscitation.2009.09.027_bib14","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1253\/circj.70.442","article-title":"Comparison of nifekalant and lidocaine for the treatment of shock-refractory ventricular fibrillation","volume":"70","author":"Tahara","year":"2006","journal-title":"Circ J"},{"key":"10.1016\/j.resuscitation.2009.09.027_bib15","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/j.1445-5994.2005.00896.x","article-title":"Randomized double-blind trial of sotalol versus lignocaine in out-of-hospital refractory cardiac arrest due to ventricular tachyarrhythmia","volume":"35","author":"Kovoor","year":"2005","journal-title":"Intern Med J"},{"key":"10.1016\/j.resuscitation.2009.09.027_bib16","first-page":"1659","article-title":"Phase I study of MS-551 (I): a single intravenous injection study","volume":"13","author":"Katoh","year":"1997","journal-title":"J Clin Ther Med"},{"key":"10.1016\/j.resuscitation.2009.09.027_bib17","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1161\/01.CIR.102.21.2665","article-title":"Cardiovascular drugs. Dofetilide","volume":"102","author":"Mounsey","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.resuscitation.2009.09.027_bib18","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0735-1097(86)80512-5","article-title":"Effect of lidocaine and bretylium on energy requirements for transthoracic defibrillation: experimental studies","volume":"7","author":"Kerber","year":"1986","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.resuscitation.2009.09.027_bib19","doi-asserted-by":"crossref","first-page":"607","DOI":"10.2165\/00003495-200868050-00004","article-title":"Effect of drugs on defibrillation capacity","volume":"68","author":"Dopp","year":"2008","journal-title":"Drugs"},{"key":"10.1016\/j.resuscitation.2009.09.027_bib20","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1016\/S0735-1097(98)00160-0","article-title":"Effects of amiodarone and its active metabolite desethylamiodarone on the ventricular defibrillation threshold","volume":"31","author":"Zhou","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.resuscitation.2009.09.027_bib21","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/S0735-1097(96)00559-1","article-title":"Can a class III antiarrhythmic drug improve electrical defibrillation efficacy during ventricular fibrillation?","volume":"29","author":"Murakawa","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.resuscitation.2009.09.027_bib22","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1540-8159.2009.02172.x","article-title":"The effect of dofetilide on ventricular defibrillation thresholds","volume":"32","author":"Simon","year":"2009","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.resuscitation.2009.09.027_bib23","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.resuscitation.2005.02.014","article-title":"Epinephrine and vasopressin during cardiopulmonary resuscitation","volume":"66","author":"Zhong","year":"2005","journal-title":"Resuscitation"},{"key":"10.1016\/j.resuscitation.2009.09.027_bib24","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1161\/01.CIR.82.6.2027","article-title":"Effect of epinephrine and lidocaine therapy on outcome after cardiac arrest due to ventricular fibrillation","volume":"82","author":"Weaver","year":"1990","journal-title":"Circulation"},{"key":"10.1016\/j.resuscitation.2009.09.027_bib25","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/S0196-0644(98)70031-9","article-title":"Do advanced cardiac life support drugs increase resuscitation rates from in-hospital cardiac arrest? The OTAC study group","volume":"32","author":"van Walraven","year":"1998","journal-title":"Ann Emerg Med"}],"container-title":["Resuscitation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300957209005036?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300957209005036?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T02:41:46Z","timestamp":1759545706000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0300957209005036"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["S0300957209005036"],"URL":"https:\/\/doi.org\/10.1016\/j.resuscitation.2009.09.027","relation":{},"ISSN":["0300-9572"],"issn-type":[{"type":"print","value":"0300-9572"}],"subject":[],"published":{"date-parts":[[2010,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nifekalant versus lidocaine for in-hospital shock-resistant ventricular fibrillation or tachycardia","name":"articletitle","label":"Article Title"},{"value":"Resuscitation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.resuscitation.2009.09.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}